Anthony V Daza Selected Research

A-151892

9/2004

In vitro and in vivo characterization of a novel naphthylamide ATP-sensitive K+ channel opener, A-151892.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony V Daza Research Topics

Disease

3	Overactive Urinary Bladder (Overactive Bladder) 09/2004 - 10/2002
2	Neuralgia (Stump Neuralgia) 01/2009 - 01/2009
2	Hyperalgesia 01/2009 - 03/2008
1	Postoperative Pain 04/2012
1	Pain (Aches) 01/2009
1	Lower Urinary Tract Symptoms 09/2004
1	Stress Urinary Incontinence 08/2002

Drug/Important Bio-Agent (IBA)

3	Adenosine Triphosphate (ATP)IBA 09/2004 - 10/2002
2	CannabinoidsIBA 01/2009 - 01/2009
2	Freund's AdjuvantIBA 01/2009 - 03/2008
1	GTP-Binding Proteins (G-Protein)IBA 01/2009
1	CB2 Cannabinoid ReceptorIBA 01/2009
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2009
1	cyclopropanecarboxylic acidIBA 01/2009
1	A-836339IBA 01/2009
1	AmidesIBA 01/2009
1	Capsaicin (Zostrix)FDA Link 01/2009
1	A-151892IBA 09/2004
1	9- (3- bromo- 4- fluorophenyl)- 2,3,5,6,7,9- hexahydrothieno(3,2- b)quinolin- 8(4H)- one 1,1-dioxideIBA 10/2002
1	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2002
1	Phenylpropanolamine (Dexatrim)FDA Link 08/2002
1	Midodrine (Midon)FDA LinkGeneric 08/2002

Therapy/Procedure

1	Analgesia 04/2012